- Home
- VYNE vs CELZ Comparison
VYNE vs CELZ Comparison
Compare VYNE & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VYNE
- CELZ
- Stock Information
- Founded
- VYNE 2003
- CELZ 1998
- Country
- VYNE United States
- CELZ United States
- Employees
- VYNE N/A
- CELZ N/A
- Industry
- VYNE Biotechnology: Pharmaceutical Preparations
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- VYNE Health Care
- CELZ Health Care
- Exchange
- VYNE Nasdaq
- CELZ Nasdaq
- Market Cap
- VYNE 7.9M
- CELZ 7.4M
- IPO Year
- VYNE 2018
- CELZ N/A
- Fundamental
- Price
- VYNE $0.30
- CELZ $3.52
- Analyst Decision
- VYNE Buy
- CELZ
- Analyst Count
- VYNE 2
- CELZ 0
- Target Price
- VYNE $8.00
- CELZ N/A
- AVG Volume (30 Days)
- VYNE 1.7M
- CELZ 34.2K
- Earning Date
- VYNE 11-06-2025
- CELZ 11-07-2025
- Dividend Yield
- VYNE N/A
- CELZ N/A
- EPS Growth
- VYNE N/A
- CELZ N/A
- EPS
- VYNE N/A
- CELZ N/A
- Revenue
- VYNE $476,000.00
- CELZ $6,000.00
- Revenue This Year
- VYNE N/A
- CELZ N/A
- Revenue Next Year
- VYNE N/A
- CELZ N/A
- P/E Ratio
- VYNE N/A
- CELZ N/A
- Revenue Growth
- VYNE N/A
- CELZ N/A
- 52 Week Low
- VYNE $0.28
- CELZ $1.69
- 52 Week High
- VYNE $4.30
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- VYNE 31.65
- CELZ 56.61
- Support Level
- VYNE $0.30
- CELZ $3.39
- Resistance Level
- VYNE $0.33
- CELZ $3.74
- Average True Range (ATR)
- VYNE 0.02
- CELZ 0.16
- MACD
- VYNE 0.02
- CELZ 0.01
- Stochastic Oscillator
- VYNE 39.80
- CELZ 58.45
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.